SCHEMBL17290249

SCHEMBL17290249

COc1ccc(-c2nn(C)c(O)c2C)cc1F

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.47
KDM4E B2RXH2 3/20 0.47
MAPK1 P28482 2/20 0.46
HTT P42858 1/20 0.46
NPSR1 Q6W5P4 1/20 0.46
NPC1 O15118 3/20 0.43
RAB9A P51151 3/20 0.43
SMN1; SMN2 Q16637 3/20 0.43
MAPT P10636 2/20 0.43
LMNA P02545 1/20 0.43
L3MBTL1 Q9Y468 2/20 0.42
ERN1 O75460 1/20 0.42
PIK3CD O00329 1/20 0.42
ABL1 P00519 1/20 0.42
EGFR P00533 1/20 0.42
HCK P08631 1/20 0.42
SRC P12931 1/20 0.42
PIK3CA P42336 1/20 0.42
PIK3CB P42338 1/20 0.42
MTOR P42345 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16660185 0.86 SRC (0.43) KDM4ENPSR1SMN1; SMN2MAPTLMNA
SCHEMBL17290345 0.82 ERN1 (0.50) ALDH1A1KDM4EMAPK1HTTNPSR1
SCHEMBL17290498 0.78 PIK3CD (0.38) ALDH1A1KDM4EMAPK1HTTNPSR1
SCHEMBL17290446 0.78 GRM5 (0.34) ALDH1A1HTTNPSR1PIK3CDABL1
SCHEMBL17290647 0.76 MEN1 (0.47) ALDH1A1KDM4EMAPK1NPSR1NPC1
SCHEMBL17290602 0.76 MAPK14 (0.45) ALDH1A1KDM4ESMN1; SMN2MAPTGRM5
SCHEMBL17290393 0.74 ALDH1A1 (0.49) ALDH1A1KDM4EMAPK1HTTNPSR1
SCHEMBL23399473 0.72 SMN1; SMN2 (0.40) ALDH1A1NPC1RAB9ASMN1; SMN2MAPT
SCHEMBL2558362 0.71 ERN1 (0.44) ALDH1A1KDM4EMAPK1HTTNPSR1
SCHEMBL15331480 0.71 ERN1 (0.44) ALDH1A1KDM4EMAPK1HTTNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3148972-B1 PYRAZOLONE DERIVATIVES AS NITROXYL DONORS CARDIOXYL PHARMACEUTICALS INC (US) 2019-08-21 EP disclosed
US-9682938-B2 Pyrazolone derivatives as nitroxyl donors CARDIOXYL PHARMACEUTICALS, INC. (US) 2017-06-20 US disclosed
EP-3148972-A1 PYRAZOLONE DERIVATIVES AS NITROXYL DONORS Cardioxyl Pharmaceuticals Inc. (US) 2017-04-05 EP disclosed
WO-2015183839-A1 PYRAZOLONE DERIVATIVES AS NITROXYL DONORS CARDIOXYL PHARMACEUTICALS, INC. (US) 2015-12-03 WO disclosed
US-20150344437-A1 PYRAZOLONE DERIVATIVES AS NITROXYL DONORS THE JOHNS HOPKINS UNIVERSITY 2015-12-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150344437-A1 PYRAZOLONE DERIVATIVES AS NITROXYL DONORS TNNI3, PFKP, NOX5 ALDH1A1 1883/4885KDM4E 3651/4885MAPK1 3982/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.